Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Sold by RTW Investments LP

RTW Investments LP decreased its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 2.9% during the 4th quarter, Holdings Channel.com reports. The fund owned 2,569,687 shares of the company’s stock after selling 76,016 shares during the period. Establishment Labs accounts for about 1.8% of RTW Investments LP’s holdings, making the stock its 23rd largest position. RTW Investments LP owned 0.09% of Establishment Labs worth $118,385,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of ESTA. Quarry LP acquired a new position in Establishment Labs during the 4th quarter worth about $27,000. R Squared Ltd acquired a new position in Establishment Labs during the 4th quarter worth about $36,000. KLP Kapitalforvaltning AS acquired a new position in Establishment Labs during the 4th quarter worth about $161,000. Hood River Capital Management LLC lifted its stake in Establishment Labs by 236.4% during the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company’s stock worth $273,000 after acquiring an additional 4,160 shares in the last quarter. Finally, Handelsbanken Fonder AB lifted its stake in Establishment Labs by 32.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company’s stock worth $378,000 after acquiring an additional 2,000 shares in the last quarter. Institutional investors and hedge funds own 72.91% of the company’s stock.

Analyst Ratings Changes

ESTA has been the topic of several research reports. Stephens reissued an “overweight” rating and set a $52.00 target price on shares of Establishment Labs in a research note on Thursday, March 6th. Needham & Company LLC upgraded Establishment Labs from a “hold” rating to a “buy” rating and set a $48.00 price target on the stock in a report on Wednesday. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, Establishment Labs presently has a consensus rating of “Moderate Buy” and an average target price of $55.83.

Establishment Labs Price Performance

Shares of NASDAQ ESTA opened at $36.62 on Friday. The stock’s 50-day moving average is $34.40 and its two-hundred day moving average is $38.32. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. Establishment Labs Holdings Inc. has a 1-year low of $26.56 and a 1-year high of $60.09. The company has a market cap of $1.06 billion, a price-to-earnings ratio of -14.19 and a beta of 0.73.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings results on Wednesday, May 7th. The company reported ($0.70) earnings per share for the quarter, topping the consensus estimate of ($0.83) by $0.13. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The company had revenue of $41.38 million for the quarter, compared to the consensus estimate of $41.15 million. During the same quarter in the prior year, the business earned ($0.58) EPS. Establishment Labs’s revenue was up 11.3% on a year-over-year basis. Analysts forecast that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.